Go to the list of all blogs
M. Benett's Avatar
published in Blogs
Sep 21, 2026
XP Inc. (XP): Could Shares Reach the $25 Level? (+25% Upside)

XP Inc. (XP): Could Shares Reach the $25 Level? (+25% Upside)

Key Takeaways

  • The target: The $25 level sits roughly 25% above XP's recent price near $20 and aligns with several Wall Street price objectives, including UBS's $25 target.
  • Bullish case: A "Strong Buy" consensus, a discounted valuation, heavy capital returns, and record asset gathering support the path higher.
  • Biggest risk: Elevated Brazilian interest rates, intense competition from incumbent banks, and a shift toward lower-fee fixed-income products.
  • Technical picture: The 52-week high near $23 is the key resistance level to clear before $25 becomes reachable.
  • Takeaway: $25 is plausible but not automatic; it likely requires a more favorable Brazilian rate environment and continued earnings growth.

Why the $25 Level Matters for XP

XP (XP Inc.), a leading Brazilian technology-enabled investment platform, has traded in a 52-week range of roughly $14.80 to $23.13. With shares near $20, the $25 mark represents a meaningful but not unreasonable step higher — about 25% above the recent price. It is also a natural psychological round number and a level already cited in analyst research, making it a focal point for investors searching for an "XP stock price target."

XP's Current Standing in the Market

XP is one of Brazil's largest independent investment platforms, serving about 4.8 million active clients with roughly R$1.5 trillion in assets under custody (AUC) and more than R$2.2 trillion in combined client assets. In the second quarter of 2026, gross revenue rose 8% year over year to R$5.1 billion, while earnings before taxes (EBT) climbed 15% to R$1.57 billion. Return on equity (ROE) reached 22.5%, underscoring the platform's profitability. Shares trade at a price-to-earnings (P/E) ratio near 10, a discount to the company's longer-term average multiple. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

What Could Drive Shares Higher

Several forces support the idea that XP can climb toward $25. First, the platform continues to gather assets, with net inflows in the second quarter nearly tripling year over year. Growing AUC feeds a recurring fee base that can sustain revenue even when trading activity cools. Second, the company is diversifying beyond brokerage, with wholesale banking revenue up 32% year over year and corporate segment revenue growing sharply.

Third, capital returns are unusually strong for a growth-oriented financial firm. Management has combined share repurchases with dividends, and analysts at JPMorgan have estimated a potential shareholder yield in the low-teens percentage range. Buybacks reduce the share count, mechanically lifting earnings per share (EPS) and supporting the price. Finally, a favorable turn in Brazil's interest-rate cycle could be a powerful catalyst: lower rates typically encourage clients to shift out of cash and daily-liquidity products into higher-fee investments, boosting XP's take rate.

Obstacles That Could Slow Progress

The obstacles are equally real. Brazil's Selic benchmark rate remains elevated, which favors traditional banking products and increases competition from incumbents. XP has also experienced a sharp shift in client demand toward short-duration, daily-liquidity fixed-income products, which generate lower revenue than longer-dated corporate bonds. This mix pressure can dilute monetization even as client assets grow.

Market volatility and mark-to-market swings in credit portfolios have periodically weighed on results, and issuer-services revenue can soften when debt capital markets activity declines. For U.S.-listed shares, currency fluctuations in the Brazilian real add another layer of risk to any "XP price forecast."

Where Analysts Stand on Price Targets

The consensus among analysts is decisively constructive. Recent estimates put the average 12-month price target near $23, with the highest estimates reaching roughly $26. UBS maintains a Buy rating with a $25 target, while Morgan Stanley and JPMorgan have cited targets around $26. Itaú BBA upgraded the shares in late August, while Goldman Sachs has also maintained a positive view. This clustering means $25 is not an outlier — it sits squarely within the range of published analyst objectives, though it sits modestly above the consensus mean.

Key Technical Levels to Watch

From a technical standpoint, the path to $25 runs through the 52-week high near $23, which acts as the primary resistance level. A decisive break above that zone on strong participation would open the door to the psychologically important $25 round number. On the downside, the $18 to $19 area has provided support in recent months, with the 52-week low near $14.80 marking the deeper safety zone. The stock's long-term structure remains constructive, but $25 will not be reached until the prior high is cleared and held.

Monitoring Momentum With AI Tools

For traders monitoring whether XP can build the momentum needed to challenge $25, Tickeron's AI Daily Buy/Sell Signals offer a data-driven way to track changing conditions. The product uses artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on shifting market conditions, technical behavior, and AI-driven analysis. Traders can use these signals to discover new opportunities, monitor existing positions, and identify evolving market trends more efficiently. Exploring AI-generated signals can be a practical complement to a disciplined technical and fundamental review.

My Take on the Path Forward

A move to $25 for XP appears realistic but is by no means guaranteed. The strongest arguments in its favor are a strongly positive analyst consensus, a valuation that remains below the company's historical average, aggressive capital returns, and the potential for a Brazilian rate-cutting cycle to reignite revenue growth. The principal risks are elevated domestic interest rates, competitive pressure from larger banks, and an unfavorable shift toward lower-fee products. Investors should monitor Brazil's monetary policy, quarterly net inflows and AUC trends, the take rate, and whether shares can sustain a breakout above the $23 resistance level. From what I see, this setup warrants close attention in the quarters ahead.

Using Tickeron for Deeper Research

In my own process, I often turn to Tickeron’s suite of AI tools to cross-check fundamentals and technical setups. The AI Daily Buy/Sell Signals have been especially useful for spotting shifts in momentum across Brazilian financial names like XP, helping me stay objective when weighing both the bullish catalysts and the rate-related risks. It is a practical addition to standard research without replacing core analysis.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: XP

XP in -1.66% downward trend, sliding for three consecutive days on September 15, 2026

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where XP declined for three days, in 247 of 312 cases, the price declined further within the following month. The odds of a continued downward trend are 79%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for XP moved out of overbought territory on September 09, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator moved out of overbought territory. In 24 of the 31 cases, the stock moved lower in the following days. This puts the odds of a move lower at 77%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 41 of 52 cases where XP's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 79%.

XP broke above its upper Bollinger Band on September 02, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 21, 2026. You may want to consider a long position or call options on XP as a result. In 62 of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 74%.

The Moving Average Convergence Divergence (MACD) for XP just turned positive on August 21, 2026. Looking at past instances where XP's MACD turned positive, the stock continued to rise in 28 of 37 cases over the following month. The odds of a continued upward trend are 76%.

XP moved above its 50-day moving average on August 21, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for XP crossed bullishly above the 50-day moving average on August 26, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 7 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 44%.

Following a +3.38% 3-day Advance, the price is estimated to grow further. Considering data from situations where XP advanced for three days, in 207 of 287 cases, the price rose further within the following month. The odds of a continued upward trend are 72%.

The Aroon Indicator entered an Uptrend today. In 152 of 197 cases where XP Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 77%.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating steady price growth. XP’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 43 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 57 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 87 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.107) is normal, around the industry mean (4.744). P/E Ratio (10.176) is within average values for comparable stocks, (30.560). Projected Growth (PEG Ratio) (0.970) is also within normal values, averaging (0.823). Dividend Yield (0.010) settles around the average of (0.016) among similar stocks. P/S Ratio (6.325) is also within normal values, averaging (16.763).

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. XP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock worse than average.

Notable companies

The most notable companies in this group are Morgan Stanley (NYSE:MS), Goldman Sachs Group (NYSE:GS), Charles Schwab Corp (The) (NYSE:SCHW), Gold.com Inc. (NYSE:GOLD).

Industry description

These banks specialize in underwriting (helping companies with debt financing or equity issuances), IPOs, facilitating mergers and other corporate reorganizations and acting as a broker or financial advisor for institutions. They might also trade securities on their own accounts. Investment banks potentially thrive on expanding its network of clients, since that could help them increase profits. Goldman Sachs, Morgan Stanley and CME Group Inc are some of the largest investment banking companies.

Market Cap

The average market capitalization across the Investment Banks/Brokers Industry is 13.24B. The market cap for tickers in the group ranges from 590 to 318.17B. MS holds the highest valuation in this group at 318.17B. The lowest valued company is FSSLD at 590.

High and low price notable news

The average weekly price growth across all stocks in the Investment Banks/Brokers Industry was 3%. For the same Industry, the average monthly price growth was 11%, and the average quarterly price growth was 10%. NCPL experienced the highest price growth at 65%, while IPST experienced the biggest fall at -25%.

Volume

The average weekly volume growth across all stocks in the Investment Banks/Brokers Industry was 125%. For the same stocks of the Industry, the average monthly volume growth was 45% and the average quarterly volume growth was 16%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 66
P/E Growth Rating: 64
Price Growth Rating: 55
SMR Rating: 74
Profit Risk Rating: 85
Seasonality Score: -6 (-100 ... +100)
View a ticker or compare two or three
XP
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a technology-driven financial services platform, which offers services in Investments, Technology, Career, and Financial Market.

Industry InvestmentBanksBrokers

Profile
Details
Industry
N/A
Address
20, Genesis Close
Phone
+1345 1130750429
Employees
8069
Web
https://www.xpinc.com
Interact to see
Advertisement
Shares of ALDX are down about 73.02% in premarket trading, plunging from a prior close near 4.13 dollars to roughly 1.11 dollars after a major regulatory setback. The collapse follows fresh confirmation that the U.S. Food and Drug Administration has again declined to approve reproxalap for dry eye disease, issuing another Complete Response Letter that questions efficacy.
Shares of MVST are down about 25% in premarket trading today compared with the prior close. The slide follows a sharp reassessment of the company’s outlook as investors react to new information and recent volatility in high‑beta battery and EV names.
Solaris Energy Infrastructure’s stock SEI jumped roughly 13% in today’s session, extending a sharp recent rebound from early-March lows. The move is driven by ongoing post-earnings momentum after strong Q4 and full‑year 2025 results and raised guidance highlighted rapid growth in its power solutions business.
Shares of LMND are trading approximately +10% higher intraday on Tuesday, March 17, 2026, rising from a prior close of $57.74 to around $63.51. Primary catalyst: Morgan Stanley upgraded LMND to an 'Overweight' rating and raised its price target to $85 from $80.
Shares of ICHR surged approximately +15% intraday on Tuesday, March 17, 2026, trading near $48.98 versus a prior closing price of $42.59. The primary catalyst is a high-profile analyst upgrade by Stifel, with analyst Brian Chin upgrading the stock to Buy citing improved cyclical strength and conviction in the company's revenue and margin trajectory.
NBIS shares are down approximately 10.00% in Tuesday's session, falling from a prior close of $129.85 to around $116.87. The primary catalyst is Nebius Group's pre-market announcement of a proposed $3.75 billion convertible senior notes offering, sparking dilution concerns.
TME shares fell over 20% today, with the stock sliding from the mid‑$15s toward the low‑$13s in the wake of its Q4 2025 report and earnings call, extending a pre‑market drop of roughly 12–13%.
HUYA shares fell over 11% today, dropping from the mid‑$3 range toward the low‑$3s following the company’s Q4 2025 earnings release before the U.S. market open. Q4 total net revenues rose about 16% year over year to roughly CNY 1.74 billion, with full‑year 2025 revenues up around 7% to CNY 6.5 billion, but the market had already priced in a rebound after a difficult 2024.​
CWCO fell over 9% today, trading around the low‑$31 range versus recent levels in the mid‑$30s to near $39, as the market reacted negatively to Q4 2025 results and forward commentary. Full‑year 2025 results showed stable earnings and dividend growth but a roughly 9% decline in services revenue to about $46.3 million, reflecting a slowdown in project‑based construction work.
SMTC shares dropped over 8% today after the company reported Q4 results that met or modestly beat Street estimates but showed the slowest year‑over‑year revenue growth in several quarters, at about 9.3% to roughly $274–275 million.
AXTI shares slipped more than 6% today, reversing part of a powerful rally that had recently driven the stock to a 52‑week high above $47 and more than doubled its price year‑to‑date. Q4 2025 revenue of about $23.0 million missed consensus by roughly $1.2 million and fell 8–18% year over year and sequentially, while the company posted another GAAP net loss of around $3.5 million (–$0.08 per share).
Shares of SailPoint, Inc. (SAIL) are tumbling approximately 12% in premarket trading on March 18, 2026, after the company released its fiscal fourth-quarter and full-year 2026 results before the market opened. While Q4 revenue came in slightly above consensus at $295 million (+23% year-over-year), investors were rattled by disappointing forward guidance for fiscal 2027.
Shares of KC surged approximately +17% in premarket trading on March 18, 2026, from a prior close of $13.12 to approximately $15.35. The primary catalyst is Kingsoft Cloud's release of its unaudited Q4 and full-year 2025 financial results before the U.S. market open, which appear to have significantly exceeded analyst expectations.
AngloGold Ashanti (AU) shares tumbled approximately 7% in premarket trading on March 18, 2026, extending a multi-week downtrend that has erased nearly 20% of the stock's value since late January highs. The primary catalyst driving the decline is persistent investor concern over AngloGold's lowered 2026 production guidance, with the company projecting gold output of 2.80–3.17 million ounces — a roughly 3% decline from its 2025 production of 3.1 million ounces.
AAOI shares surged approximately 10.90% in premarket trading on March 18, 2026, rising from a prior close of $86.33 to $95.74. The primary catalyst is strong positive sentiment generated at OFC 2026 — the Optical Fiber Communications Conference and Exhibition — where Applied Optoelectronics unveiled breakthrough laser and transceiver technology for next-generation AI data center infrastructure.
LITE shares surged approximately +12% in early Wednesday trading on March 18, 2026, with the stock changing hands near $727 compared to a prior session close of $649.56. The primary near-term catalyst is Lumentum's S&P 500 index inclusion, effective March 23, 2026, triggering front-running by institutional investors and mandatory buying by passive index funds.
Shares of New Era Energy & Digital, Inc. (NUAI) are trading down approximately 17% during today's session, with the prior close sitting at $5.56. The decline follows the company's March 17 business update conference call and webcast, held after market hours, during which management discussed the recently filed fiscal year 2025 annual report (Form 10-K).
Shares of Regencell Bioscience Holdings (RGC) are up approximately +16% intraday on March 18, 2026, trading at $26.56 against a prior close of $22.97. No single company-specific press release is driving today's move; the rally is primarily fueled by retail-driven momentum and short squeeze mechanics.
A jump in the Producer Price Index from 0.3% to around 0.7% month‑over‑month signals that wholesale inflation is re‑accelerating, delaying Fed rate‑cut hopes and reviving the “higher for longer” rates narrative.business. Likely winners in this environment include energy and commodity producers (XOM, CVX, TTE, COP), inflation‑resilient financials (JPM, BAC), and real‑asset plays like pipelines and infrastructure, which can pass through higher prices; ETFs like XLE, XOP, XLF, DBA, GLD offer diversified exposure.
BGSI fell more than 11% today, pulling back from recent levels around the high‑$150s as investors reassessed the risk‑reward following the Q4 2025 print and major U.S. expansion plans. Full‑year 2025 sales rose 2.4% to US$3.14 billion, but same‑store sales declined 0.2%, while reported net earnings fell 25% to US$18.4 million due to US$22.6 million in acquisition and transformation costs.